Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
PalanorPalanor
Terminal News·Council··1 min read

McKesson, CD&R near $5 billion Option Care Health acquisition

McKesson and private equity firm CD&R are in negotiations to acquire infusion services provider Option Care Health for more than $5 billion.

image · feed

Palanor Wire · composed from 3 outlets · every claim links to its sources

What happened

McKesson and CD&R are in talks to acquire Option Care Health for more than $5 billion. 123 Option Care Health provides infusion services. 3

Why it matters

The acquisition would represent the latest buyout of an undervalued healthcare services company. 3

What to watch

The deal has not yet been finalized. 12

Sources · 3

  • [1]McKesson and CD&R near $5bn-plus deal to buy infusion services provider

    FT Companies

  • [2]McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports reut.rs/4zkSRyy

    Reuters · Bluesky

  • [3]McKesson, CD&R in talks for $5B deal for Option Care Health: FT

    seekingalpha.com · via Marketaux

Matched signals

Lattice signals Numen pinned to this story at publish time.

Member +

No matched signals on this story.

Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.

Upgrade →

On X right now

Top engagement posts about this topic, ranked by likes + retweets + quotes.

Member +

No high-engagement X posts captured for this topic. Either the topic is too quiet or the upstream API was unavailable when this article published.

Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.

Upgrade →

Your read

How did this article land?

Three sliders. Optional comment. Anonymous is fine.

Accuracy50
Got it wrongGot it right
Bias50
Skews leftSkews right
Importance50
NoiseMatters

Open to anyone. One response per reader.

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.